Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in STTK — Shattuck Labs, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to STTK Full portfolio

Position in STTK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,317,899
+$1,055,035 QoQ
Shares Held
189,899
+364.5% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 100 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in STTK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. STTK ranks #211 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in STTK

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,317,899 189,899
2026-03-31 $262,864 40,881
2025-12-31 $76,215 20,881
2025-09-30 $49,905 20,881
2025-06-30 $16,557 20,906
2025-03-31 $108,432 114,139
2024-12-31 $138,108 114,139
2024-09-30 $398,345 114,139
2024-06-30 $466,901 120,959
2024-03-31 $186,676 20,881
2023-12-31 $148,881 20,881
2023-09-30 $31,739 20,881
2023-06-30 $65,148 20,881
2023-03-31 $61,390 20,881
2022-12-31 $48,026 20,881
2022-09-30 $56,378 20,881
2022-06-30 $526,448 129,667
2022-03-31 $806,775 189,384
2021-12-31 $1,671,159 196,376
2021-09-30 $3,949,990 193,817
2021-06-30 $3,351,504 115,609
2021-03-31 $2,550,371 87,222
2020-12-31 $4,403,068 84,012